论文部分内容阅读
目的:研究舒利迭治疗支气管哮喘的临床效果。方法:本组研究对象为80例,入选标准均符合支气管哮喘防治常规(试行)的诊断标准。将入选患者随机分为对照组和观察组,每组患者40例,对照组患者采用糖皮质激素吸入治疗,治疗组患者采用吸入舒利迭,本次研究三个月为一个疗程。结果:两组患者在全疗程治疗后,观察组患者的有效、显效、好转、总有效均高于对照组,其中有效、无效、总有效具有统计学差异,对照组患者无效低于观察组,具有统计学差异。结论:采用舒利迭治疗支气管哮喘可取得良好的临床疗效,患者不良反应小,依从性好的特点,其安全可靠、疗效显著值得在临床中广泛应用。
Objective: To study the clinical effect of seretide on bronchial asthma. Methods: This group of 80 patients, the inclusion criteria are in line with the routine (trial) of bronchial asthma diagnostic criteria. The selected patients were randomly divided into control group and observation group, 40 patients in each group, the control group patients treated with glucocorticoid inhalation, the treatment group inhaled seretide, the study for three months as a course of treatment. Results: Two groups of patients in the whole course of treatment, the observation group of patients effective, markedly effective, improved, the total effective were higher than the control group, which effective, ineffective, the total effective with statistical differences in the control group was less effective than the observation group, With statistical differences. Conclusion: The use of Seretide treatment of bronchial asthma can achieve good clinical efficacy, patients with small adverse reactions, good compliance, and its safe and reliable, significant effect worthy of widespread use in clinical.